PA
Perceptive Advisors’s Forte Biosciences FBRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $882K | Buy |
+68,192
| New | +$882K | 0.03% | 74 |
|
|
2025
Q1 | – | Sell |
-95,742
| Closed | -$2.17M | – | 93 |
|
|
2024
Q4 | $2.17M | Hold |
95,742
| – | – | 0.06% | 84 |
|
|
2024
Q3 | $535K | Sell |
95,742
-3,169,617
| -97% | -$17.7M | 0.01% | 97 |
|
|
2024
Q2 | $1.75M | Hold |
3,265,359
| – | – | 0.04% | 93 |
|
|
2024
Q1 | $2.27M | Hold |
3,265,359
| – | – | 0.04% | 96 |
|
|
2023
Q4 | $2.68M | Hold |
3,265,359
| – | – | 0.06% | 84 |
|
|
2023
Q3 | $2.16M | Buy |
+3,265,359
| New | +$2.16M | 0.07% | 77 |
|
|
2021
Q3 | – | Sell |
-685,000
| Closed | -$23M | – | 146 |
|
|
2021
Q2 | $23M | Hold |
685,000
| – | – | 0.3% | 79 |
|
|
2021
Q1 | $23.5M | Buy |
685,000
+335,000
| +96% | +$11.5M | 0.3% | 71 |
|
|
2020
Q4 | $12.7M | Buy |
+350,000
| New | +$12.7M | 0.14% | 98 |
|